News

‘Systemic’ changes coming to advisory committee process, FDA commissioner says

The FDA is preparing to release “systemic” changes to its advisory committee process, Commissioner Rob Califf said Wednesday, building on months of hints that a high-profile part of the drug review process might face major reforms. Namandjé Bumpus Califf offered few details other than saying… … […]

News

Boston Globe: Kendall Square is no longer the area’s only biotech hotspot

The following is an excerpt from a front page story in The Boston Globe on January 31, 2024. Many have gravitated to Kendall Square partly because of its celebrated “bump factor,” the ease with which drug developers and financers can run into each other in the dense neighborhood. But that… … […]

[adinserter block="3"]
No Picture
News

Sun Life U.S. expands Health Navigator offering to group benefits clients to help more workers access healthcare

WELLESLEY, Mass., Jan. 31, 2024 /PRNewswire/ — Sun Life U.S. is now offering its healthcare navigation and advisory service to the large employer group benefits market, broadening employees’ access to care with personal guidance that helps them get the right medical diagnoses, doctors… … […]

[adinserter block="3"]
[adinserter block="3"]
News

Biogen to halt sales and development of controversial Alzheimer’s drug Aduhelm

Biogen said it will end development and commercialization of its controversial Alzheimer’s drug Aduhelm, which was approved against outside experts’ advice in mid-2021 and caused congressional inquiries and broader market pushback on pricing and efficacy. While the company didn’t take the official step of pulling the drug from the market,… … […]